Citations

Mayo Clinic

Showing 10 of 108599 citations.

Prognostic Value of the Anatomic-Physiologic Classification in Adults With Congenital Heart Disease
Egbe, Alexander C. , Miranda, William R. , Jain, C. Charles , Anderson, Jason H. , Younis, Ahmed , Abozied, Omar , Connolly, Heidi M. , Anderson, Jason , Younis, Ahmed

Circulation: Heart Failure | July 21, 2023 | Volume: 16 | Issue: 9 | Pages: No page available

10.1161/circheartfailure.122.010404 | PMID 37476989 Get It

BACKGROUND: The prognostic role of the congenital heart disease (CHD) anatomic/physiologic classification has not been systematically studied. The purpose of this study was to determine whether CHD physiologic stage provided improvement in prognostic power (to predict all-cause mortality) beyond conventional clinical risk models. METHODS: Retrospective study of adults with CHD at the Mayo Clinic (2003–2019). The CHD physiologic stage was assessed at baseline and 36 (24–48) months, and patients were classified into stages A to D at these time points. Clinical stability (remaining in the same stage), clinical improvement (moving to less advanced stage), and clinical deterioration (moving to more advanced stage) were determined at 36 months. We defined conventional clinical risk indices as age/sex, functional class, comorbidities, cardiac procedures, hepatorenal dysfunction, and ventricular/valvular dysfunction. RESULTS: Of 5321 patients, 1649 (31%), 1968 (37%), 1224 (23%), and 480 (9%) were in stages A, B, C, and D at baseline. Of 5321 patients, 4588 (86%) also had assessments at 36 months, and of these patients, 3347 (73%), 386 (8%), and 855 (19%) had clinical stability, deterioration, and improvement, respectively. Patients with clinical improvement were more likely to have undergone cardiac procedures between both assessments. Both baseline CHD physiologic stage (hazard ratio, 1.13 [95% CI, 1.09–1.17]; P <0.001, per unit increase in stage) and change in CHD physiologic stage (hazard ratio, 1.46 [95% CI, 1.32–1.61]; P =0.007, per unit increase in stage) were associated with mortality after adjustments for conventional risk indices and provided incremental improvement in prognostic power beyond conventional clinical risk models as evidence by an increase in C statistic from 0.702 (0.681–0.724) to 0.769 (0.754–0.787). CONCLUSIONS: The CHD physiologic stage can potentially be used for risk stratification, as well as to monitor disease progression and response to therapy.
Author response: Mitochondrial MICOS complex genes, implicated in hypoplastic left heart syndrome, maintain cardiac contractility and actomyosin integrity
Birker, Katja , Kalvakuri, Sreehari , Grossfeld, Paul , Colas, Alexandre R. , Bodmer, Rolf , Ge, Shuchao , Kirkland, Natalie J. , Theis, Jeanne L. , Marchant, James , Fogarty, Zachary C. , Missinato, Maria A , Engler, Adam Jeffrey , Ocorr, Karen , Nelson, Timothy J. , Olson, Timothy M. , Vogler, Georg

No container title available | July 21, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.83385.sa2 Get It

Inspiratory Muscle Strength is Related to Exertional Dyspnoea in Heart Failure with Preserved Ejection Fraction
Warner, Brit, Bruhn, Eric J., Olson, Thomas P. , Bissen, Thomas G. , Smith, Joshua R. , Smith, Joshua R. , Smith, Joshua R , Borlaug, Barry A.

European Journal of Heart Failure | July 21, 2023 | Volume: 25 | Issue: 9 | Pages: 1716-1717

10.1002/ejhf.2980 | PMID 37476916 Get It

Why Is My Ouzo Cloudy?
Carmichael, Stephen W., Oshel, Philip

Microscopy Today | July 20, 2023 | Volume: 31 | Issue: 4 | Pages: 8-9

10.1093/mictod/qaad041 Get It

Analytical Unreliability of 25 Hydroxy Vitamin D Measurements in Pre-Term Neonates
Miller, Jessica , Augustin, Roy, Sepiashvili, Lusia, Bro, Eric T., Weishuhn, Karen, Kotsopoulos, Kirsten, Brennan, Joan, Diambomba, Yenge , Higgins, Victoria , Nichols, Matthew , Beriault, Daniel R. , Yip, Paul S. F. , Bro, Eric, Beriault, Daniel R , Yip, Paul M , Singh, Ravinder J. , Kulasingam, Vathany , Taher, Jennifer

The Journal of Applied Laboratory Medicine | July 20, 2023 | Volume: 8 | Issue: 5 | Pages: 856-870

10.1093/jalm/jfad033 | PMID 37473432 Get It

Abstract Background Vitamin D supplementation is common practice for neonates and infants due to limited stores of vitamin D at birth. Although not commonly encountered, vitamin D toxicity can occur due to over-supplementation. However, toxic concentrations are often not included in method validation experiments, and assays often are not validated in the neonatal population. Methods We compared serial 25 hydroxy vitamin D [25(OH)D] measurements in pre-term neonates receiving 25(OH)D supplementation and identified 12 patients wherein concentrations of 25(OH)D were above 50 ng/mL (125 nM) that required additional investigations as the 25(OH)D results did not match the clinical picture. Available samples were compared across 4 immunoassay platforms (LIAISON XL, Roche Cobas e602, Abbott Alinity i, and Siemens Centaur XP) and LC–MS/MS. Results Concentrations of 25(OH)D observed on one individual immunoassay platform (LIAISON XL) fluctuated substantially between subsequent blood draws in select neonates with elevated concentrations. Serum samples from these patients showed variable agreement between LC–MS/MS and other immunoassay platforms. These fluctuations were not explained by the presence of 3-epimer-25(OH)D or 24,25(OH)2D. Conclusions Although we were unable to identify a cause for the variable elevated results, our findings suggest that neonatal 25(OH)D measurements alone should not be used for assessment of nutritional monitoring, and that clinical correlation and other laboratory parameters including ionized calcium should be considered.
Escalation strategies, management, and outcomes of acute myocardial infarction‐cardiogenic shock patients receiving percutaneous left ventricular support
Patlolla, Sri Harsha , Gilbert, Olivia , Belford, P. Matthew , Jentzer, Jacob C. , Pisani, Barbara , Applegate, Robert J., Zhao, David , Vallabhajosyula, Saraschandra , Gilbert, Olivia N , Jentzer, Jacob C , Zhao, David X , Vallabhajosyula, Saraschandra , Harsha Patlolla, Sri , Morris, Benjamin N.

Catheterization and Cardiovascular Interventions | July 20, 2023 | Volume: 102 | Issue: 3 | Pages: 403-414

10.1002/ccd.30786 | PMID 37473420 Get It

AbstractBackgroundThere are limited national‐level data on the contemporary practices of mechanical circulatory support (MCS) use in acute myocardial infarction‐cardiogenic shock (AMI‐CS).MethodsWe utilized the Healthcare Cost and Utilization Project‐National/Nationwide Inpatient Sample data (2005–2017) to identify adult admissions (>18 years) with AMI‐CS. MCS devices were classified as intra‐aortic balloon pump (IABP), percutaneous left ventricular assist devices (pLVAD), or extracorporeal membrane oxygenation (ECMO). We evaluated trends in the initial device used (IABP alone, pLVAD alone or ≥2 MCS devices), device escalation, bridging to durable LVAD/heart transplantation, and predictors of in‐hospital mortality and device escalation.ResultsAmong 327,283 AMI‐CS admissions, 131,435 (40.2%) had an MCS device placed with available information on timing of placement. IABP, pLVAD, and ≥2 MCS devices were used as initial device in 120,928 (92.0%), 8202 (6.2%), and 2305 (1.7%) admissions, respectively. Most admissions were maintained on the initial MCS device with 1%–1.5% being escalated (IABP to pLVAD/ECMO, pLVAD to ECMO). Urban, medium, and large‐sized hospitals and acute multiorgan failure were significant independent predictors of MCS escalation. In admissions receiving MCS, escalation of MCS device was associated with higher in‐hospital mortality (adjusted odds ratio: 1.56, 95% confidence interval: 1.38–1.75; p < 0.001). Admissions receiving durable LVAD/heart transplantation increased over time in those initiated on pLVAD and ≥2 MCS devices, resulting in lower in‐hospital mortality.ConclusionsIn this 13‐year study, escalation of MCS in AMI‐CS was associated with higher in‐hospital mortality suggestive of higher acuity of illness. The increase in number of durable LVAD/heart transplantations alludes to the role of MCS as successful bridge strategies.
Jaktinib and momelotinib for the treatment of myelofibrosis—Birds of a feather?
Tefferi, Ayalew

American Journal of Hematology | July 20, 2023 | Volume: 98 | Issue: 10 | Pages: 1517-1519

10.1002/ajh.27036 | PMID 37471656 Get It

Comb Detection for Measuring Shear Wave Propagation
Lee, Hyoung-Ki , Holmes, Philip M. , Greenleaf, James F. , Urban, Matthew W. , Urban, Matthew W

IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control | July 20, 2023 | Volume: 70 | Issue: 9 | Pages: 1135-1145

10.1109/tuffc.2023.3297394 | PMID 37471186 Get It

Updates in the care of the alloimmunized pregnant patient: A transfusion medicine and clinical laboratory perspective
Abels, Elizabeth , Adkins, Brian D. , Booth, Garrett S. , DiGuardo, Margaret , Ding, Jia Jennifer, Guarente, Juliana , Klein, Monica, Woo, Jennifer S. , Jacobs, Jeremy W. , DiGuardo, Margaret A , Woo, Jennifer S , Jacobs, Jeremy W , Booth, Garrett , Adkins, Brian David , Allen, Elizabeth S. , Stephens, Laura D. , Tormey, Christopher A.

American Journal of Clinical Pathology | July 20, 2023 | Volume: 160 | Issue: 5 | Pages: 441-443

10.1093/ajcp/aqad083 | PMID 37471256 Get It